Objectives
- Describe the financial impact of HCV treatment
- Identify current restrictions to HCV treatment common among third party payers
- Illustrate successful navigation through the prior authorization and appeal process
- Review criteria and options for patient assistance programs (PAP)
Speaker
Autumn Bagwell PharmD BCPS
Browse more
Language: English
Topic(s): Clinical Program Management, Comorbidities, Coinfections, & Complications, Viral Hepatitis Coinfection
Resource type: Online and Self-Paced Learning
Add comment